MedPath
NMPA Approval

Rivaroxaban Tablets

国药准字HJ20220100

Hexal AG

December 30, 2022

Drug Information

利伐沙班片

片剂

15mg

化学药品

December 30, 2022

December 29, 2027

Company Information

Applicant Company

Hexal AG

Industriestraβe 25, 83607 Holzkirchen, Germany

Manufacturing Company

oman pharmaceutical products co. llc

Plot No.101, Raysut Industrial Estate, P.O.Box 2240, Postal Code-211, Salaah, Sultanat of Oman

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利伐沙班片 - NMPA 批准文号 | MedPath